Devereaux, Philip J

Published purpose

The objectives of this funding opportunity are to: • Leverage and build on existing infrastructure (domestic and international) to support a cohesive, efficient and responsive clinical trials ecosystem in Canada. • Leverage active partnerships within the clinical trials ecosystem to support the development and implementation of clinical trials as part of pandemic preparedness and health emergency response plans. • Reinforce the clinical trials ecosystem through activities and processes that are efficient, sustainable, and which advance equitable access to clinical trials for Canadians regardless of geography, race/ethnicity, and socioeconomic status. • Reinforce the involvement of patient and community perspectives across all applicable activities, in alignment with the SPOR Patient Engagement Framework. • Maximize research impact and knowledge mobilization¿within and beyond the Consortium to support and facilitate inclusive, evidence informed health policy, decision making and planning. NOTE: Individual research projects conducted by the Consortium and its members are not an eligible cost through this funding opportunity and therefore must be funded by other sources. Funding through the grant that results from this funding opportunity is intended to support ecosystem strengthening, capacity building and coordination functions only.